Per Bengt Akerstrom
Director/Board Member at Preelumina Diagnostics AB
Network origin in Per Bengt Akerstrom first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Preelumina Diagnostics AB
7
| Subsidiary | 7 | |
Rim & Reson Musikproduktion HB
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Per Bengt Akerstrom via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABLIVA AB | Pharmaceuticals: Major | Chairman | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer | |
| University of Toronto | College/University | Graduate Degree | |
| London School of Economics & Political Science | College/University | Undergraduate Degree | |
| University of Lund | College/University | Director/Board Member Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
WC Likvid AB
 WC Likvid AB Real Estate DevelopmentFinance WC Likvid AB owns and manages movable and immovable property. The company was founded by Tadeusz Wojciech Wieloch on June 5, 2009 and is headquartered in Staffanstorp, Sweden. | Real Estate Development | Director/Board Member | |
Nordic Bioscience A/S
 Nordic Bioscience A/S Miscellaneous Commercial ServicesCommercial Services Nordic Bioscience A/S engages in preclinical and clinical drug development. It specializes in precision medicine using biomarker technologies. The company was founded by Claus Henrik Christiansen and Bente Juel Riis in 1991 and is headquartered in Herlev, Denmark. | Miscellaneous Commercial Services | Sales & Marketing | |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Chairman Founder | |
| GUARD THERAPEUTICS INTERNATIONAL AB | Pharmaceuticals: Major | Chairman Chairman Chief Executive Officer Founder Founder Chairman Founder | |
Finja Five AB
 Finja Five AB Information Technology ServicesTechnology Services Finja Five AB develops and manages the concept child-friendly-computing (CFC) for schools and at home. It operates as a knowledge enterprise within the business segment of information and communication technology (ICT). The firm’s main business is CFC for emerging markets, globally. The company was founded in 2008 and is headquartered in Lund, Sweden. | Information Technology Services | Director/Board Member | |
| Ideonfonden AB | Director/Board Member | ||
| XINTELA AB | Biotechnology | Chairman Director/Board Member | |
| Stanbridge Corp. BV | Chief Executive Officer | ||
| ACUCORT AB | Pharmaceuticals: Major | Chairman | |
| Bauló Capital Belgium SA | Director/Board Member | ||
| ENORAMA PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Ermén Produktion och Redovisning AB | Director/Board Member | ||
| BioInvent Finans AB | Director/Board Member | ||
| PROSTALUND AB | Medical Specialties | Director/Board Member | |
Magle AB
 Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The company is based in Lund, Sweden. | Chemicals: Major Diversified | Sales & Marketing | |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| INTELLEGO TECHNOLOGIES AB | Electronic Components | Chairman | |
| ABERA BIOSCIENCE AB | Biotechnology | Director/Board Member | |
| C Glad Consulting AB | Director/Board Member | ||
Medeon AB
 Medeon AB Miscellaneous Commercial ServicesCommercial Services Medeon AB is a life science research park located in Malmö, Sweden. The Swedish company offers various services such as incubation, office and conference spaces, and laboratory facilities to its partner companies. Medeon focuses on several areas of research, including diabetes, nanomedicine, and pharma development. The private company has a diverse range of partner companies, including Ascelia Pharma, Biora AB/Straumann, and Gordiamkey. The CEO of the company is Ulf G. Andersson. | Miscellaneous Commercial Services | Director/Board Member | |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chairman | |
Omnio AB
 Omnio AB BiotechnologyHealth Technology Omnio AB is a biotechnical research and Swedish development company. The private company is based in Umeå, Sweden. | Biotechnology | Chairman | |
Merozyne Therapeutics AB
 Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chairman | |
Ermén Konsult Enskild Firma
 Ermén Konsult Enskild Firma Miscellaneous Commercial ServicesCommercial Services Ermén Konsult Enskild Firma provides professional, scientific and technical services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BEWETE AB
 BEWETE AB Specialty StoresRetail Trade BEWETE AB is a Swedish company that trades caravans, passenger cars, and light motor vehicles. | Specialty Stores | Corporate Officer/Principal | |
Swede Unipharma AB
 Swede Unipharma AB Financial ConglomeratesFinance Swede Unipharma AB provides investment services. The Swedish company was founded by Mats Otto Persson. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal | |
Sinntaxis AB
 Sinntaxis AB Miscellaneous Commercial ServicesCommercial Services Sinntaxis AB conducts research and development in neurosciences and pharmaceutical drugs. The company is based in Lund, Sweden. The CEO of the Swedish company is Tomas Jörgen Eriksson. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Ermén & Sand Hb | Corporate Officer/Principal | ||
| Magle Life Sciences AB | Sales & Marketing | ||
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chairman | |
CarryGenes Therapeutics AB
 CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman | |
Region Skåne Holding AB
 Region Skåne Holding AB Advertising/Marketing ServicesCommercial Services Region Skåne Holding AB is a private company based in Malmö, Sweden, with subsidiaries in Sweden. The Swedish company provides a free service that helps businesses improve their online presence and increase their visibility on Google search and maps. By creating a unique and eye-catching company profile, potential customers can easily find important information such as opening hours, address, and contact details. In collaboration with the city of Malmö, the company is working on developing sustainable tourism through the promotion of train travel. The goal is to reduce the negative climate impact of tourism by encouraging travelers to choose train travel over flights. The company's strategies are based on cooperation with actors who can make a difference, such as Skånetrafiken, SJ, tour operators, and property owners of train stations. Region Skåne Holding AB aims to empower Skåne's event and hospitality industry. | Advertising/Marketing Services | Director/Board Member | |
| OVB Freehold Ltd. | Director/Board Member | ||
| Immodulate Pharma AB | Director/Board Member | ||
| Lundoch Diagnostics AB | Chairman | ||
Preelumina AB
 Preelumina AB Pharmaceuticals: MajorHealth Technology PrePreelumina AB develops pharmaceutical products for diagnosis of preeclampsia. The firm investigates the mechanisms behind the development of preeclampsia and identified a unique treatment method based on an endogenous protein. The company was founded by Tomas Jörgen Eriksson in 2008 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| HMC Mödravårdsmottagning AB | Chief Executive Officer | ||
| S.R. Hansson Medicinsk konsult AB | Chief Executive Officer | ||
| Kombinator Affärsutveckling AB | Director/Board Member |
Statistics
International
| Sweden | 45 |
| United Kingdom | 3 |
| Belgium | 3 |
| Canada | 2 |
| Denmark | 2 |
Sectoral
| Health Technology | 21 |
| Commercial Services | 7 |
| Consumer Services | 4 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 40 |
| Chairman | 23 |
| Corporate Officer/Principal | 12 |
| Chief Executive Officer | 10 |
| Founder | 10 |
Most connected contacts
- Stock Market
- Insiders
- Per Bengt Akerstrom
- Company connections
